✦ LIBER ✦

P.2.f.018 Aripiprazole for the augmentation of antidepressant therapy in inadequate responders diagnosed with major depressive disorder

✍ Scribed by Hou, Y.M.; Huang, L.C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.g.008 Efficacy and tolerability of o

✍ D. Shin; S. Hong 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

P.2.f.003 Comparison of aripiprazole aug

✍ Lee, K.; Lee, J.B.; Park, Y.W.; Lee, J.H.; Lee, S.J.; Koo, B.H.; Sung, H.M.; Che 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 76 KB

P.2.f.026 An open clinical trial of adju

✍ Kim, H.; Lee, K.J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 55 KB

P.2.g.003 Aripiprazole for the treatment

✍ A.R. Cho; W.S. Kang; S.M. Lee; M.H. Hong; J.K. Park 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Cost Effectiveness Analysis for the Use

✍ Polanco, A.C.; Ascencio, I.S.I.; Salazar, A.; González, L.A.; Pizarro, M.; Soto, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

P.2.c.038 Long-term efficacy of agomelat

✍ G.M. Goodwin; F. Rouillon; R. Emsley 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 70 KB